Base Editing Hematopoietic Stem Cell and T Cell Gene Therapy for CD40L-HyperIgM Syndrome: Single Patient Study
Clinical trial NCT06959771 · RECRUITING
Trial details
- NCT number
- NCT06959771
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-16
- Primary completion
- 2027-10-28
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.